跳至主要内容
临床试验/NL-OMON40594
NL-OMON40594招募中不适用

Development of an assay for detection of Circulating Endothelial Cell (CEC) and Circulating Endothelial Progenitor cell (CEP) by fluorescence-activated cell sorting (FACS) in cancer patients and healthy individuals. - Development and validation of the CEC/CEP FACS assay

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • bInclusion criteria cancer patients:
  • 1. Patients with histological or cytological proof of metastatic cancer.
  • 2. Age * 18 years
  • 3. Able and willing to give written informed consent
  • 4. Able and willing to undergo blood sampling ;Inclusion criteria healthy volunteers:
  • 1. Age * 18 years
  • 2. Able and willing to give written informed consent
  • 3. Able and willing to undergo blood sampling

排除标准

  • Exclusion criteria cancer patients:
  • 1. Patients with known alcoholism, drug addiction, psychotic disorders in the history and/or other reasons, for which they are not amenable for adequate follow up.
  • 2. Uncontrolled infectious disease or known HIV-1 or HIV-2 type patients ;Exclusion criteria healthy volunteers:
  • 1. Patients with known alcoholism, drug addiction, psychotic disorders in the history and/or other reasons, for which they are not amenable for adequate follow up.
  • 2. Uncontrolled infectious disease or known HIV-1 or HIV-2 type patients
  • 3. Prior history of malignancy, renal disease, cardiovascular disease.

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验

Development of an assay for detection of Circulating... | 临床试验